002653.SZ Haisco Pharmaceutical Group Co., Ltd. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
05:09
Jan 12
Jan 12
Haisco licensing validates innovative pipeline.
Haisco's license collaboration with Air & Access/Nexus validates its China-generated data and innovation. It receives over $100 million upfront, up to $1 billion total plus equity, royalties and sublicense income, and a 19.9% NewCo stake. With 48 programs, about 30 active pipeline assets, and a partnership-led overseas strategy, multiple assets can drive global expansion despite domestic pricing pressure.
HIGH
About 002653.SZ Investor Commentary
Across the available history and selected sources, Buzzberg tracks 002653.SZ (Haisco Pharmaceutical Group Co., Ltd.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Lency Gu.